Scientific Council

Camillo Ricordi, MD, PhD

Professor and Director of the Institute for Study of Diabetes and Cell Transplantation Centre at the University of Miami, Florida. He invented a method of isolation of the cells producing insulin from the pancreas, which has led to a successful transplant to reverse diabetes. The method is now employed worldwide. Mr Ricordi's research focus includes reversal of autoimmunology, graft tolerability, inflammation modulation and regenerative medicine to prevent diseases and prolong healthy life (Healthspan). In 2020, he led an international team to successfully complete the first FDA-approved controlled trial in the treatment of the most serious cases of COVID-19 with stem cell infusions. Unprecedented results resulted in 100% survival within one month of treatment for those who were less than 85 years of age, compared to 42% survival in the control group. Ricordi and his colleagues have recently launched a programme www.fit4pandemic.com to help the general public prevent the progression of the disease in the most serious forms of viral, autoimmune and age-related diseases to prolong healthy life (Healthspan). He received over 100 distinctions and awards, including the World Prize in Surgery (Genewa, CH) and Outstanding Scientific Achievement Award (American Diabetes Association). He was knighted by the President of Italy, included in the US National Academy of Inventors and appointed to the Supreme Council of Health of Italy. Ricordi is the author of more than 1,150 scientific publications that have been cited more than 45,700 times. Its H-index is 102, and as an inventor, he was awarded 27 patents.

Professor Artur Tadeusz Bossowski, MD, PhD

Head of the Department of Paediatrics, Endocrinology and Diabetology with a Cardiology Unit, Medical University of Białystok (UMB) since October 2009. Since 2011, he has been full professor appointed by the President of Poland and since 2019 he has been a regular professor approved by UMB Senate. He is a specialist in pediatrics, endocrinology, diabetology, and paediatric endocrinology and diabetology, and completed specialty in pediatric cardiology. He is the Deputy Chairperson of the Board of Clinics and a member of the Commission for post-graduate education at the Children's University Clinical Hospital of Białystok. He is a lecturer and member of the presidium of the Human Development Committee of the Polish Academy of Sciences in the developmental age section. He also serves as a voivodeship consultant for paediatric endocrinology and diabetology. He is also a manager of specialization of three paediatricians and 8 specialists in paediatric endocrinology and diabetology. In the years 2009-2017 he was a member (two terms) of the Management Board of the Polish Society of Paediatric Endocrinology and Diabetes. On the behalf of the Association, he was a coordinator for multicenter clinical trials in pediatric endocrinology and diabetology in Poland (he develops collaborations in immunogenetic research in selected endocrinopathies in children and as part of the Strategmed-Cellular Therapy project for type 1 diabetes, based on the development of artificial regulatory lymphocytes CD4+CD25+CD127- and an anti-CD20 antibody, a randomized study), as well as scientific cooperation with European centres (participation in the European project on the identification of mutations in the IGF-1 receptor in short stature patients and thyroid dysfunction in newborns and infants of mothers with autoimmune thyroid diseases). He participates in post-graduate education (courses and internships) organised by the Postgraduate Medical Center in Warsaw (CMKP) in the field of paediatrics, paediatric endocrinology and diabetology. Lecture at initial and testing courses at Children's Memorial Health Centre (IP CZD) in Warsaw, within the framework of the CMKP, in the field of paediatric endocrinology, and at the Children's University Clinical Hospital of Białystok in the field of paediatrics. For many years he has been a Visiting Professor of Queen Mary University of London, Royal London Hospital, UK and Visiting Professor of FIRS Laboratories RSR in Cardiff, UK. He initiated a series of paediatric endocrinology and diabetology workshops addressed at general practitioners, paediatricians, internists, diabetologists and endocrinologists from Podlasskie Voivodeship. Since 2009, he has been an active member of the Coordination Team for the Growth Hormone Therapy at the Children's Health Centre (IP CZD) in Warsaw. In 2017, he received the TOP IF Award for 2016 of the UMB Rector. In 2018, in post-surgical thyroid tissues in children he detected expression of ZnT8 zinc transporter in follicular cells of thyroid and C cells based on WB, IF and RT-PCR- methods as a new autoantigen. Between 2001 and 2018, he was distinguished ten times and was awarded the Tomasz Romer award by the Polish Society of Paediatric Endocrinology and Diabetology for the best works in the field of pediatric endocrinology published in peer-reviewed journals (Pediatrics, Journal Endocrinological Investigation, Autoimmunity, Hormone Research). Between 2001 and 2018, he was distinguished on several occasions for scientific achievements with the teams of 1st, 2nd and 3rd degree of His Magnificence Rector of the UMB. In 2006, he received a Team Award of the Minister of Health for a series of 6 works on pathogenic factors in selected endocrinopathies in children, adolescents and adults with respect to immunometabolic disorders. Since January 2019 he has been the coordinator of the nationwide screening programme for early detection of type 1 diabetes in families with a history of this condition. Project coordinator as part of the European Society for Tyreology "Pysterological Assessments of antithyroid antibodies in newborns and infants of mothers with autoimmune thyroid diseases in pregnancy". Cooperation with FIRS RSR Lab. Cardiff, UK. In 2020, he won the KIDS competition for the best project in Poland concerning telemetry in children with arrhythmia. Participation in the projects: •Strategmed- “Cellular therapy of type 1 diabetes, based on the proliferation of artificial regulatory lymphocytes CD4+CD25+CD127- and an anti-CD20 antibody, a randomized trial" in collaboration with the Department of Clinical Immunology and Department of Paediatric Immunology, Endocrinology and Diabetology, Medical University of Gdańsk, in the period 2003-2005, head of research project KBN No 3PO5E00525 entitled: “Evaluation of selected subpopulations of lymphocytes, intracellular cytokines, adhesion and costimulation molecules and selected human thyroperoxidase epitopes in the tissue material in children and adolescents with thyroid developmental age diseases." • In 2010-14, a co-implementer of research project No N N407 14463, funded by the Ministry of Science and Higher Education entitled: "The effect of biological treatment on selected biochemical and ultrasound markers of the preclinical phase of the atherosclerotic process in children with juvenile idiopathic arthritis", in 2011-2014, the project manager approved by the National Science Centre (NCN) (No N N407 216640) entitled: "Analysis of apoptosis, number and function of regulatory T cells in the pathogenesis of thyroid autoimmune disorders of developmental age”. • On behalf of the PTEiDD, coordinator for the development of standards in thyrotoxicology. In October 2010, he was the main organiser of the National Paediatric Cardiology Meeting in Białowieża. In 2013, he was the editor-chief of the “Tyreologia wieku dziecięcego" of the Medical Tribune Polska publishing house. He participated in the creation of a handbook for specialization in pediatric endocrinology of PZWL 2018 publishing house, where he was a scientific editor of chapter 5 dedicated to thyroid diseases in children. On the other hand, in the "Diabetology of developmental age", edited by Małgorzata Myśliwiec, by the PZWL 2018 publishing house, he was a co-author of the chapters on the occurrence of the most common endocrinopathies with type 1 diabetes in children. In 2019, with Professor Andrzej Lewiński, he co-created the chapters in the Pediatrics Manual of the Medycyna Praktyczna publishing house on thyroid inflammation and pituitary resistance to thyroid hormones in children. He is a guest editor of two prestigious journals: Genes (IF-4) and IJMS (IF-5.9), special edition of Thyroid Diseases and Thyroid Cancer. The scientific achievements include a total of 177 publications, including 13 chapters in books and 441 convention communications. 97 original papers were published in journals with an Impact Factor index of a total of 225 points.

Agata Przemysława Chobot, MD, PhD

Head of the Department of Paediatrics, Medical Faculty, University of Opole Graduate of the Faculty of Medicine, Medical University of Silesia in Katowice. In 2010, she obtained a PhD in medical sciences, and in 2017 the degree of dr. hab. n. med. She defended her doctoral work at the Medical University of Warsaw, with thesis title: “Type 1 diabetes in the paediatric population - its consequences, comorbidities and epidemiological and social aspects”. Specialist in Paediatric Gastroenterology and Pediatrics. She has completed numerous scientific internships and courses in prestigious university centres, including: ISPAD Physician Research School, Joslin Diabetes Center, Harvard Medical School, Boston (USA), University of Miami Miller School of Medicine (USA), Schwarzwald-Baar Klinikum Villingen-Schwenningen (Germany), Salamanca, University of Salamanca (Spain), Leicester, Leicester Royal Infirmary (United Kingdom). Author of 43 publications in national and international journals and 4 book chapters (IF: 84.6; Hirsch index: 9 (Scopus)) on topics related to diabetology and pediatric gastroenterology. Lecturer at scientific conferences in Poland and abroad on topics related to diabetology and pediatric gastroenterology. In 2014-2016 she was a project manager of the grant of the Ministry of Science and Higher Education entitled "Iuventus Puls" (IP2012 007672): "Evaluation of the prevalence of Helicobacter pylori infection in children with type 1 diabetes." Additional Scientific Activities: 2018-2020 peer reviewer for journals: International Journal of Chronic Diseases, Polish Achieves of Internal Medicine, Pediatric Diabetes 2015 - 2018. Supportive Manager for the Student’s Scientific Club at the Paediatric Diabetology Clinic of the Medical University of Silesia in Katowice; 2016-2019 Auxiliary research promoter for the doctoral thesis of Katarzyna Górowska-Kowolik, physician - defended at the Faculty of Medicine with the Department of Medicine and Dentistry in Zabrze of the Medical University of Silesia in Katowice, with the distinction in 2019, 2015-2017, Auxilliary research promoter for the doctoral thesis of Agnieszka Szymlak, physician - defended at the Faculty of Medicine with the Department of Medicine and Dentistry in Zabrze of the Medical University of Silesia. Membership in organizations and scientific societies: since 2017 Polish Society of Paediatrics, Hepatology and Nutrition of Children since 2010 The International Society of Pediatric and Adolescent Diabetes ISPAD - (from 2016 member JENIOUS, groups of young scientists belonging to ISPAD; from 2021 - JENIOUS Leader) Polish Society of Paediatrics of the Polish Diabetes Association

Kamil Chwojnicki, MD, PhD

Vice dean of the Faculty of Medicine of the Medical University of Gdańsk. Assistant at the Department of Anaesthesiology and Intensive Care, Medical University of Gdańsk. Specialises in neurological diseases. Graduate of the Medical University of Gdańsk. Between 2001 and 2002 he was a scholarship grantee of the Socrates-Erasmus program at the University of Claude Bernard, Lyon. After he returned to Gdańsk, he was employed at the Clinic of Adult Neurology. In 2008, he received his doctoral degree in medical sciences, he defended his doctoral work entitled: "Assessment of quality of secondary prevention after ischaemic stroke in a representative sample of Gdynia residents." He obtained his doktor habilitowany degree in 2018. Participant of numerous scholarships and trainings, especially in the area of ischemic stroke treatment and prevention. Co-authored approximately 100 scientific publications, convention reports and chapters in handbooks. He also worked together with the Office of the Marshall of the Pomeranian Voivodeship to improve stroke monitoring and prevention in the region. He was a lecturer on courses for neurologists, GPs and anesthesiologists.

Professor Przemysława Jarosz-Chobot MD, PhD

Head of the Department of Paediatrics, Department of Diabetology, Faculty of Medicine, Medical University of Silesia in Katowice In the period 2010 - 2019 she was a Voivodeship Consultant on Diabetology and since 2019 Voivodeship Consultant on Paediatric Endocrinology and Diabetology for the Voivodeship of Silesia. Since 2016 Member of the Polish Academy of Sciences (PAN) for the assessment of diabetes epidemiology in Poland and the quality of public statistics. She has been a member of the Polish Academy of Sciences in the Human Development Committee since 2019. She is a graduate of the Medical University of Silesia. She has participated in numerous scientific internships and courses in Polish and foreign prestigious diabetes centres, including Erasmus University of Rotterdam (Netherlands), WHO Epidemiological Course Cambridge (UK), Wright University, Dayton (USA). She has worked in numerous national and international scientific teams (e.g. EUCADET - European Children and Adolescent Diabetes and Endocrine Trials network, Hvidøre Study Group). She has been the researcher of many national and international scientific grants (including NCBiR STRATEGMED TREGS, EURODIAB, EUBIROD, INTERPRET, INNODIA). National Scientific Programmes: 1999-2002 KBN 4PO5EO73/8 Selected genetic markers in children with type 1 diabetes and their family members in the upper population of Silesia (main researcher) 2000-2001 of the Batory Foundation 18399/99/WB/W "Diabetology and endocrinology of the developmental age on the Internet (project manager) 2004-2004 PB2/KBN/040/P04/08 Intercollegiate (Institute of Oncology, University of Silesia, Silesian University of Technology, ŚAM), Approved methods of modern functional genomics to address significant problems in biotechnology and medicine (main researcher) 2005-2008 National Foundation program of the Great Ochestra of Christmas Charity (WOSP) - Assessment of insulin pump of the youngest children with diabetes (main researcher) 2005-2008 KBN 3 T11F010 “Bioinformatic methods for identifying genetic and environmental risk factors for the most important autoimmune diseases of endocrine glands" (main researcher) 2008-2010 KBN 407 022535 Population Variability of the Glycokinase Gene (GCK) in the pathogenesis and clinical course of diabetes (main researcher) 2008-2010 KBN-6-347/08: Assessment of the role of selected genetic factors and endothelial function in the development of arterial hypertension in children with type 2 diabetes (project manager) 2010-2013 KBNN519 579938 New bioinformatic methods for testing genetic diseases of complex inheritance type (main researcher) Medical University of Łódź 2014-2015 IP2010 004770 Psychiatric problems in paediatric patients with type 1 diabetes - effects on treatment results, metabolic control and quality of life of Medical University of Łódź 2015-2016 The impact of FTO gene polymorphism on the effects of weight loss in teenage girls with type 1 diabetes (main researcher), Medical University of Białystok 2015-2018 NCBiR STRATEGMED TREGS Cell Therapy based on artificially propagated regulatory lymphocytes, consortium of SUM in Katowice, Medical University of Łódź, Medical University of Białystok and Medical University of (main researcherinternational scientific programmes (main investigator, selected): 1999- nadal EURODIAB - Epidemiology of Type 1 Diabetes Mellitus in Europe (EU grant 1989-1998) 2002- 2019 TRIGR - Trial to Reduce IDDM in the Genetically At Risk (koordynator regionalny, NIH grant) 2003, 2005 PedPumpStudy PPSG European Pediatric Pump Survey, Round 2 i 3 2003-2008 EUCID– EU - European Core Indicators in Diabetes (EU grant) 2008-2011 EUBIROD-EU - European Best Indicators through Regional Outcomes Diabetes (EU grant) 2009-2011 OCAPI - European post-marketing observational prospective cohort study of children with type 1 diabetes treated with Apidra (national coordinator) 2009-2011 INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy 2009- nadal The Hvidøre Study Group on Childhood Diabetes 2015- nadal INNODIA Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM) (grant EU) • -2020 Medtronic “ Usefulness evaluation of CGMS in analyzing and preveting hyper hypoglycemia fluction cardic surgery patients at perioperative perios treated in Cardic Surgery Intensive Care Unit” 2018 - pressent Janssen-Cilag “A randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of cannagliflozin in children and adolescents with type 2 diabetes” 2020 - present INNODIA HARVEST Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing THE FRUITS OF INNODIA 2020 GCP Certificate "Essential Good Clinical Practice" Brookwood International Academy Publications: https://orcid.org/0000-0002-1120-0994 According to the list of the Medical University of Silesia, total number of full-text papers: 639 with IF score: 217.718 and of the Ministry of Science and Higher Education: 4867.000 and authorship of 60 chapters and 6 book studies (list of ŚUM since 1998). 103 papers were cited in 1486 publications, Hirsch index: 18 database Web of Science Core Collection and Scopus, respectively. Co-author of published international and national guidelines - ISPAD Consensus Guidelines 2000, 2009, 2014 and 2018 their Polish edition (Medycyna Praktyczna - Pediatria 2001, 2010, 2015) and IDF 2012 • Polish Diabetes Association’s clinical recommendations on management of patients with diabetes, published annually (2005-present)” • Standards of insulin pump therapy in children, common position: ADA (American Diabetes Association), EASD (European Association for the Study of Diabetes), ESPE (European Society of Pediatrics Endocrinology), ISPAD (International Society for Pediatric & Adolescent Diabetes) and LWPES (Lawson Wilkins Pediatric Endocrine Society – Diabetes Care 2007;30,6,1653-1662).

Professor Iwona Kurkowska-Jastrzębska MD, PhD

Head of the 2nd Clinic of Neurology, Institute of Psychiatry and Neurology, Warsaw The main scientific and research interests concern neuroimmunology, particularly the interaction between the immune and nervous system, inflammatory diseases (multiple sclerosis, autoimmune encephalitis, paraneoplastic syndromes) and the involvement of inflammatory reaction in the pathogenesis of diseases of the nervous system (neurodegenerative diseases and epilepsy). She has recently conducted research on the search for protein biomarkers in epilepsy. She conducts both basic and clinical studies in cooperation with the Chair and Clinic of Pharmacology of the Medical University of Warsaw. For over 10 years, she has been participating in both commercial and academic clinical trials concerning epilepsy, multiple sclerosis and stroke, both as a researcher and main researcher. Currently, she coordinates non-commercial clinical trial PRECIOUS in Poland: Prevention of complications to improve prognosis in elderly patients with acute stroke financed as part of the HORYZONT 2020 program.

Professor Wojciech Młynarski MD, PhD

Head of the Department of Paediatrics, Oncology and Haematology, Medical University of Łódź. He is a pediatrician, oncologist and paediatric haematologist, paediatric endocrinologist and diabetologist. In addition to scientific work, his main clinical interest is the rational management of life-threatening conditions in the paediatric population as well as molecular diagnostics and treatment of rare diseases in children Graduate of the Faculty of Biology and Earth, University of Łódź (study course: molecular biology) and Faculty of Medicine, Medical University of Łódź (medical doctor). He received a PhD degree in 2000, and the degree of doktor habilitowany in 2004. In 2007, he received Professor's title from Lech Kaczyński, the President of the Republic of Poland, followed by taking the management of the Clinic of the Medical University of Łódź. From 2002 to 2004, he held his postdoctoral research internship at the Department of Genetics and Epidemiology, Joslin Diabetes Center, Harvard Medical School, Boston. In the period 2004-2008, he attended further scientific internships in the USA as a visiting researcher affiliated at the Harvard Medical School. Since 2019, he has been the leader of the TEAM-NET project funded by the Foundation for Polish Science with the aim of developing a novel diagnostic and therapeutic method for innate neutropenia with the use of CRISP-CAS9 technology. Since 2020, he has been the leader of the CALL-POL project funded by the Medical Research Agency, which aims to individualise the treatment of acute lymphoblastic leukaemia in children through modern molecular diagnostics and targeted therapy. He is a member of many scientific societies in Poland and abroad, among others he has served as a member of the Management Board of the Polish Diabetes Association and the International Society of Pediatric and Adolescent Diabetes and at present he is a member of the Management Board and Treasurer of the Polish Society of Pediatric Oncology and Hematology. He is also a member of the Council of the National Programme for the Treatment of Haemophilia and Related Haemorrhagic Diathesis, as well as the Team for Rare Diseases of the Ministry of Health. He is the author or co-author of over 350 scientific publications (Ministry of Science and Higher Education score >7000, IF > 1000, HI33), in such journals such as the New England Journal of Medicine, Nature Communication, Nature Chemical Biology, Nature Clinical Practice Neurology, Lancet Heamatology, Blood, Leukemia, Haematologica, Diabetes, Diabetes Care, Diabetologia, and Clinical Cancer Research.

Agnieszka Szadkowska MD, PhD

Assistant Professor at the Department of Paediatrics, Oncology, Haematology and Diabetology, Medical University of Łódź. Head of the Department of Paediatrics, Endocrinology, Diabetology and Nephrology, Paediatric Centre, Central University Hospital in Łódź. Specialist in paediatrics, diabetology, nephrology, endocrinology and paediatric diabetology. She is a member of the Polish Diabetes Association (PTD). From 2016, Director of the Management Board of PTD, Member of the Management Board of the Paediatric Section of the Polish Diabetes Association, in the period from 2008 to 2012 - Chairman of the Management Board of PTD. In addition, she is a member of: Polish Pediatric Society, Polish Society of Children's Endocrinologists and Diabetologists (member of the Management Board since 2017), European Association for the Study of Diabetes, International Society for Pediatric and Adolescent Diabetes. She is also a member of the Clinical Recommendations Team on the management of patients with diabetes in the Polish Diabetes Association. She is the author of 182 original and review publications, chapters in handbooks and monographs and 275 conference reports. Head of specialisation courses, courses for educators. Founder of the "Diabeciaki" Foundation.

Natalia Marek-Trzonkowska, MD, PhD

As a fellowship of the Kościuszko Foundation, she held postdoctoral internships at the University of Chicago, where she was involved in isolation of human pancreatic islets and developing a new method of immunologic protection of transplanted islets through their coating with live Treg cells. Laurate of national and international awards, among others, two scientific awards for clinical use of regulatory T cells by the European Federation of Immunological Societies (EFIS; Vienna and Glasgow), Polish-American Medical Society (PAMS; Chicago), Young Investigator Award granted by the International Society for Pediatric and Adolescent Diabetes (ISPAD; Istanbul), two scientific awards granted by The International Pancreas and Islet Transplant Association (IPITA, Prague) and Scholarship of the Minister of Science and Higher Education for Outstanding Achievements of Young Scholars. She continues international cooperation with centers in the UK, Spain, the Netherlands, Germany, Turkey, Italy and the United States. Co-creator of the patented TREG method.

Małgorzata Myśliwiec, MD, PhD

Specialist in pediatrics, endocrinology, diabetology, paediatric endocrinology and diabetology. Vice-Chairman of the Paediatric Section of the Polish Diabetes Association, Member of the Scientific Council at the Minister of Health, Committee for Human Science of the Polish Academy of Sciences, the Management Board of the Polish Diabetes Association, the Management Board of the Polish Society of Paediatric Endocrinology and Diabetology of. She currently participates at the ministerial level in the improvement of diagnosis and treatment of diabetes and endocrinological diseases. She was directly involved in obtaining the reimbursement for treatment with personal insulin pumps in children and adults with type 1 diabetes up to 26 years of age, and the reimbursement of electrodes for continuous glucose monitoring (CGM) and for flash glucose monitoring (FGM) system. She is a member of the Experts at the Minister of Health in the field of diabetes treatment for the performance of tasks within the framework of the Health Requirements Maps project. She also directly participated in the creation and appointment of a new position - diabetes educator - which was entered in the Qualification Tariff for Medical Positions. She was awarded a Gold and Silver Cross of Merit, and Medal of the National Education Commission for her great contribution to education and upbringing. Laureate of the Hipokrates Pomorza Award and the Honorary Trust Award “Złoty OTIS 2019". She was one of five laurates in the Women of Medicine 2017 Plebiscite. Since 5 years she has been included in the “List of One Hundred” of the most influential people in Polish medicine and the most influential people in the Polish healthcare system. Co-creator of the novel therapy for type 1 diabetes with pediatric regulatory T cells in children (TREG).

Robert Bonek, MD, PhD

Specialist in neurology, head of Department of Neurology and Clinical Neuroimmunology at Dr. Władysław Biegański Regional Specialist Hospital in Grudziądz. Member of the Management Board of the Polish Neurological Society. Since the beginning of his career he has been involved in multiple sclerosis and for several years of autoimmune disorders of the nervous system. He has gained his professional experience at the Department of Neurology of the 10th Military Clinical Hospital in Bydgoszcz. For nearly 20 years, he has participated in clinical trials, both commercial and academic, in the field of multiple sclerosis, myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. Initially as a researcher, then the principal researcher, as well as the national and regional coordinator (Central Europe). He completed his internship at the Department of Neurology and the Center of Multiple Sclerosis, IRCCS Ospendale San Rafaele, Milan. Laureate of the following awards: Foundation of Children “Zdążyć z Pomocą” in Prof. Zbigniew Religa competition; Hanka Bożyk Foundation; Polish Multiple Sclerosis Society.
Rozmiar czcionki
Wysoki kontrast